PUS1 Antibody

Code CSB-PA019086GA01HU
Size $600
Order now
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Uniprot No.
Target Names
PUS1
Alternative Names
A730013B20Rik antibody; DOBI antibody; MGC112655 antibody; MGC11268 antibody; MLASA antibody; MLASA1 antibody; mPus1p antibody; Pseudouridine synthase 1 antibody; Pseudouridylate synthase 1 antibody; PUS1 antibody; tRNA pseudouridine synthase A, mitochondrial antibody; tRNA pseudouridine(38-40) synthase antibody; tRNA pseudouridylate synthase I antibody; tRNA uridine isomerase I antibody; tRNA-uridine isomerase I antibody; TRUA_HUMAN antibody
Raised in
Rabbit
Species Reactivity
Human,Mouse,Rat
Immunogen
Human PUS1
Immunogen Species
Homo sapiens (Human)
Isotype
IgG
Purification Method
Antigen Affinity Purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
PBS with 0.1% Sodium Azide, 50% Glycerol, pH 7.3. -20°C, Avoid freeze / thaw cycles.
Tested Applications
ELISA,WB
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Converts specific uridines to PSI in a number of tRNA substrates. Acts on positions 27/28 in the anticodon stem and also positions 34 and 36 in the anticodon of an intron containing tRNA. Involved in regulation of nuclear receptor activity through pseudouridylation of SRA1 RNA.
Gene References into Functions
  1. results show that the NTD of ERalpha and AR contains a novel RBM that directly binds SRA, and that STR5 can serve as a novel class of RNA inhibitor of ERalpha and AR signaling by interfering with Pus1p-mediated SRA pseudouridylation PMID: 22998747
  2. Investigation of the sequence and structural requirements for hPus1p activity on human tRNASer. PMID: 22102571
  3. We identified one novel homozygous null mutation in a familial case. It predicts a nonsense mutation at glutamine 154 (Q154X) that would lead to a protein lacking the 266 C-terminal amino acids PMID: 19731322
  4. Missense mutation in pseudouridine synthase 1 causes mitochondrial myopathy and sideroblastic anemia PMID: 15108122
  5. MLASA is associated with absent or greatly reduced tRNA pseudouridylation at specific sites, implicating this pathway in its molecular pathogenesis. PMID: 15772074
  6. A new homozygous stop mutation (E220X)predicts a protein missing 208/427 amino acid residues on the C terminus. The nuclear isoform has an N-terminal extension absent in the mature mitochondrial isoform. PMID: 17056637
  7. Three residues (R116, Y173, R267) that correspond to amino acids known to compose the active site of TruA, a bacterial Psi synthase that is homologous to Pus1p, were mutated in human Pus1p. PMID: 18648068

Show More

Hide All

Involvement in disease
Myopathy with lactic acidosis and sideroblastic anemia 1 (MLASA1)
Subcellular Location
[Isoform 1]: Mitochondrion.; [Isoform 2]: Nucleus.
Protein Families
TRNA pseudouridine synthase TruA family
Tissue Specificity
Widely expressed. High levels of expression found in brain and skeletal muscle.
Database Links

HGNC: 15508

OMIM: 600462

KEGG: hsa:80324

STRING: 9606.ENSP00000365837

UniGene: Hs.592004

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*